Challenging choices: liver transplantation for hepatocellular carcinoma.

PubWeight™: 0.83‹?›

🔗 View Article (PMC 1356207)

Published in Ann Surg on February 01, 2004

Authors

Stuart J Knechtle

Articles by these authors

Urinary-cell mRNA profile and acute cellular rejection in kidney allografts. N Engl J Med (2013) 7.40

Liver transplantation for the treatment of hepatocellular carcinoma. Oncology (Williston Park) (2011) 2.14

Biologics in organ transplantation. Transpl Int (2012) 2.06

Outcomes at 3 years of a prospective pilot study of Campath-1H and sirolimus immunosuppression for renal transplantation. Transpl Int (2006) 1.68

Donation after cardiac death: the University of Wisconsin experience with liver transplantation. Ann Surg (2005) 1.67

Developmental exposure to noninherited maternal antigens induces CD4+ T regulatory cells: relevance to mechanism of heart allograft tolerance. J Immunol (2007) 1.64

Evaluation of clinical outcomes of prophylactic versus preemptive cytomegalovirus strategy in liver transplant recipients. Transpl Int (2013) 1.50

Selenium-binding protein-1 in smooth muscle cells is downregulated in a rhesus monkey model of chronic allograft nephropathy. Am J Transplant (2005) 1.45

Alemtuzumab induction and triple maintenance immunotherapy in kidney transplantation from donors after cardiac death. Transpl Int (2008) 1.44

Donation after cardiac death: the university of wisconsin experience with renal transplantation. Am J Transplant (2004) 1.26

Human CD4+CD25low adaptive T regulatory cells suppress delayed-type hypersensitivity during transplant tolerance. J Immunol (2007) 1.23

Risk factors and outcomes in post-liver transplantation bile duct stones and casts: A case-control study. Liver Transpl (2008) 1.23

Elevation of CXCR3-binding chemokines in urine indicates acute renal-allograft dysfunction. Am J Transplant (2004) 1.19

Overcoming Chronic Rejection-Can it B? Transplantation (2009) 1.17

Metastable tolerance to rhesus monkey renal transplants is correlated with allograft TGF-beta 1+CD4+ T regulatory cell infiltrates. J Immunol (2004) 1.17

Donation after cardiac death: the University of Wisconsin experience. Ann Transplant (2004) 1.14

Campath-1H use in pediatric renal transplantation. Am J Transplant (2005) 1.13

T-lymphocyte alloresponses of Campath-1H-treated kidney transplant patients. Transplantation (2006) 1.12

Macrophages driven to a novel state of activation have anti-inflammatory properties in mice. J Immunol (2008) 1.10

The evolving role of alemtuzumab (Campath-1H) for immunosuppressive therapy in organ transplantation. Transpl Int (2006) 1.08

CXCR3-mediated T-cell chemotaxis involves ZAP-70 and is regulated by signalling through the T-cell receptor. Immunology (2007) 1.04

Infected bilomas in liver transplant recipients, incidence, risk factors and implications for prevention. Am J Transplant (2004) 1.03

Underutilization of pancreas donors. Transplantation (2003) 0.98

Urine osteoprotegerin and monocyte chemoattractant protein-1 in lupus nephritis. J Rheumatol (2009) 0.98

Liver transplantation for HELLP syndrome. Liver Transpl (2005) 0.96

Nonhuman primate infections after organ transplantation. ILAR J (2008) 0.95

Noninvasive detection of acute and chronic injuries in human renal transplant by elevation of multiple cytokines/chemokines in urine. Transplantation (2009) 0.94

Simultaneous pancreas-kidney transplantation from donation after cardiac death: successful long-term outcomes. Ann Surg (2005) 0.93

Monotherapy with the novel human anti-CD154 monoclonal antibody ABI793 in rhesus monkey renal transplantation model. Transplantation (2004) 0.93

Correlation between human leukocyte antigen antibody production and serum creatinine in patients receiving sirolimus monotherapy after Campath-1H induction. Transplantation (2004) 0.92

Hepatic enrichment and activation of myeloid dendritic cells during chronic hepatitis C virus infection. Hepatology (2012) 0.91

Tolerogenic therapies in transplantation. Front Immunol (2012) 0.88

Racial and socioeconomic disparities in pediatric and young adult liver transplant outcomes. Liver Transpl (2013) 0.88

Interleukin-15 receptor blockade in non-human primate kidney transplantation. Transplantation (2010) 0.87

Altered distribution of H60 minor H antigen-specific CD8 T cells and attenuated chronic vasculopathy in minor histocompatibility antigen mismatched heart transplantation in Cxcr3-/- mouse recipients. J Immunol (2007) 0.87

Surveillance of acute rejection in baboon renal transplantation by elevation of interferon-gamma inducible protein-10 and monokine induced by interferon-gamma in urine. Transplantation (2004) 0.87

The effectiveness of locoregional therapies versus supportive care in maintaining survival within the Milan criteria in patients with hepatocellular carcinoma. J Vasc Interv Radiol (2010) 0.85

Transplant versus resection for the management of hepatocellular carcinoma meeting Milan Criteria in the MELD exception era at a single institution in a UNOS region with short wait times. J Surg Oncol (2013) 0.85

Determination of the functional status of alloreactive T cells by interferon-gamma kinetics. Transplantation (2006) 0.84

Chronic allograft nephropathy uniformly affects recipients of cadaveric, nonidentical living-related, and living-unrelated grafts. Transplantation (2003) 0.84

Superior long-term results of simultaneous pancreas-kidney transplantation from pediatric donors. Am J Transplant (2004) 0.83

Infected bilomas in liver transplant recipients: clinical features, optimal management, and risk factors for mortality. Clin Infect Dis (2004) 0.82

The Association Between Hospital Finances and Complications After Complex Abdominal Surgery: Deficiencies in the Current Health Care Reimbursement System and Implications for the Future. Ann Surg (2015) 0.82

Piceatannol in combination with low doses of cyclosporine A prolongs kidney allograft survival in a stringent rat transplantation model. Transplantation (2002) 0.82

Hepatocellular carcinoma lesion characterization: single-institution clinical performance review of multiphase gadolinium-enhanced MR imaging--comparison to prior same-center results after MR systems improvements. Radiology (2011) 0.82

Urine proteomics in kidney transplantation. Transplant Rev (Orlando) (2013) 0.81

Rapamycin antagonizes cyclosporin A- and tacrolimus (FK506)-mediated augmentation of linker for activation of T cell expression in T cells. Int Immunol (2003) 0.81

Antibody-mediated rejection of the kidney after simultaneous pancreas-kidney transplantation. J Am Soc Nephrol (2008) 0.80

Induction immunosuppression in liver transplantation: a review. Transpl Int (2013) 0.80

Transient CD86 expression on hepatitis C virus-specific CD8+ T cells in acute infection is linked to sufficient IL-2 signaling. J Immunol (2010) 0.80

Effect of immunosuppressants on T-cell subsets observed in vivo using carboxy-fluorescein diacetate succinimidyl ester labeling. Transplantation (2003) 0.80

Alemtuzumab induction and antibody-mediated kidney rejection after simultaneous pancreas-kidney transplantation. Transplantation (2009) 0.79

Immunotoxin-treated rhesus monkeys: a model for renal allograft chronic rejection. Transplantation (2003) 0.79

Alemtuzumab induction and recurrence of glomerular disease after kidney transplantation. Transplantation (2007) 0.79

The role of B cells in solid organ transplantation. Semin Immunol (2011) 0.79

Primary vascularization of the graft determines the immunodominance of murine minor H antigens during organ transplantation. J Immunol (2011) 0.79

Donor-specific HLA-antibody-mediated humoral rejection in a liver transplant recipient fully reversed with plasmapheresis and immunoglobulin. Clin Transpl (2006) 0.78

Systems biological analyses reveal the hepatitis C virus (HCV)-specific regulation of hematopoietic development. Hepatology (2015) 0.77

Long-term outcomes in simultaneous pancreas-kidney transplantation: lessons relearned. Clin Transpl (2003) 0.77

Impact of Leukocyte Function-Associated Antigen-1 Blockade on Endogenous Allospecific T Cells to Multiple Minor Histocompatibility Antigen Mismatched Cardiac Allograft. Transplantation (2015) 0.76

Post-transplant lymphoproliferative disorder associated with immunosuppressive therapy for renal transplantation in rhesus macaques (Macaca mulatta). Exp Toxicol Pathol (2013) 0.75

Reply to Vanhove et al. Transpl Int (2013) 0.75

Cross-talk between T and B Cells in the Germinal Center following Transplantation. Transplantation (2016) 0.75

Liver transplantation for biliary atresia: 19-year, single-center experience. Exp Clin Transplant (2004) 0.75

The Volume-outcome Relationship in Deceased Donor Kidney Transplantation and Implications for Regionalization. Ann Surg (2017) 0.75

Immune status assay (ISA): a noninvasive procedure for studying allograft rejection. Transpl Immunol (2004) 0.75

Annual literature review for clinical transplants 2005. Clin Transpl (2005) 0.75

Incidental living donor nephrectomy: a unique expansion of the donor pool. Nephrol Dial Transplant (2005) 0.75

Liver transplantation 2007: where do we go from here? Curr Opin Organ Transplant (2007) 0.75

Cytokine kinetics profiling in pediatric renal transplant recipients. Pediatr Transplant (2010) 0.75

Starting well: induction immunosuppression after organ transplantation. Transpl Int (2013) 0.75